A comparative study with mammography and physical examination showed that automated water-path whole-breast sonography contributed to the care of at least one-half of 786 study patients (separate report). Clinical application then followed in an additional 2530 women in whom there were 107 biopsy-proven cancers, 69 discrete biopsied benign lesions, and 121 biopsies of poorly defined lesions, usually some form of fibrocystic disease without a discrete mass. Breast sonography demonstrated 72% of the cancers and detected six cancers not seen on mammography. Although there was considerable overlapping of sonographic characteristics of benign and malignant diseases, most lesions were differentiated. Only 10% of the solid benign lesions had some characteristic of malignancy, and in 90% of the infiltrating duct carcinomas, findings suggested the histologic diagnosis. While breast sonography must be considered a complement to physical examination and mammography, the procedure can reliably differentiate the histologic types of at least 83% of discrete benign lesions and 75% of cancers. In 90% of all solid breast lesions, sonography differentiated benign and malignant processes.
No takes yet. Share an insight, caveat, or question.
Egan et al. (1984) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: